Clinical Trial Detail

NCT ID NCT01743950
Title A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

malignant glioma

Therapies

Bevacizumab

Age Groups: senior adult

No variant requirements are available.